Arkadios Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $875K | Buy |
6,917
+828
| +14% | +$105K | 0.03% | 611 |
|
2025
Q1 | $779K | Buy |
6,089
+1,997
| +49% | +$255K | 0.03% | 542 |
|
2024
Q4 | $541K | Sell |
4,092
-64
| -2% | -$8.46K | 0.03% | 516 |
|
2024
Q3 | $605K | Sell |
4,156
-313
| -7% | -$45.6K | 0.03% | 476 |
|
2024
Q2 | $613K | Sell |
4,469
-56
| -1% | -$7.69K | 0.04% | 411 |
|
2024
Q1 | $621K | Sell |
4,525
-116
| -2% | -$15.9K | 0.05% | 341 |
|
2023
Q4 | $630K | Sell |
4,641
-259
| -5% | -$35.2K | 0.05% | 313 |
|
2023
Q3 | $599K | Sell |
4,900
-707
| -13% | -$86.5K | 0.06% | 295 |
|
2023
Q2 | $712K | Sell |
5,607
-561
| -9% | -$71.2K | 0.08% | 239 |
|
2023
Q1 | $797K | Buy |
6,168
+1,568
| +34% | +$203K | 0.09% | 219 |
|
2022
Q4 | $604K | Sell |
4,600
-333
| -7% | -$43.7K | 0.08% | 255 |
|
2022
Q3 | $577K | Sell |
4,933
-1,809
| -27% | -$212K | 0.09% | 247 |
|
2022
Q2 | $793K | Buy |
6,742
+1,124
| +20% | +$132K | 0.12% | 205 |
|
2022
Q1 | $732K | Buy |
5,618
+752
| +15% | +$98K | 0.1% | 237 |
|
2021
Q4 | $743K | Buy |
4,866
+107
| +2% | +$16.3K | 0.1% | 234 |
|
2021
Q3 | $769K | Sell |
4,759
-850
| -15% | -$137K | 0.11% | 207 |
|
2021
Q2 | $917K | Sell |
5,609
-8,537
| -60% | -$1.4M | 0.11% | 215 |
|
2021
Q1 | $2.13M | Buy |
14,146
+343
| +2% | +$51.6K | 0.35% | 71 |
|
2020
Q4 | $2.09M | Buy |
13,803
+8,527
| +162% | +$1.29M | 0.44% | 60 |
|
2020
Q3 | $737K | Buy |
5,276
+424
| +9% | +$59.2K | 0.37% | 59 |
|
2020
Q2 | $681K | Buy |
4,852
+1,942
| +67% | +$272K | 0.38% | 55 |
|
2020
Q1 | $314K | Buy |
2,910
+151
| +5% | +$16.3K | 0.2% | 117 |
|
2019
Q4 | $336K | Buy |
+2,759
| New | +$336K | 0.2% | 111 |
|